Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

The drug combination was safe and showed promise in treating advanced tumors.

Laser treatments are the most effective for porokeratotic adnexal ostial nevus.

The method effectively images and correlates elements and metabolites in tissue samples at a micron scale.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Baricitinib helps regrow hair in teens with severe alopecia areata.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Botulinum toxin is not effective for treating male hair loss.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Baricitinib shows promise in treating severe hair loss.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

The new treatment showed promise in managing eyebrow hair loss.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

Biotin helps maintain hair follicle growth by affecting cell death and survival signals.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.